Hepp Z - Search Results

1

Rosenberg JE, Mamtani R, Sonpavde GP, Loriot Y, Duran I, Lee JL, Matsubara N, Vulsteke C, Castellano D, Sridhar SS, Pappot H, Gurney H, Bedke J, van der Heijden MS, Galli L, Keam B, Masumori N, Meran J, O'Donnell PH, Park SH, Grande E, Sengeløv L, Uemura H, Skaltsa K, Campbell M, Matsangou M, Wu C, Hepp Z, McKay C, Powles T, Petrylak DP. Rosenberg JE, et al. Among authors: hepp z. Eur Urol. 2024 Jun;85(6):574-585. doi: 10.1016/j.eururo.2024.01.007. Epub 2024 Feb 28. Eur Urol. 2024. PMID: 38418343 Free article. Clinical Trial.

2

Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.

Milowsky MI, O'Donnell PH, Hoimes CJ, Petrylak DP, Flaig TW, Moon HH, Friedlander TW, Mar N, McKay RR, Srinivas S, Gravis G, Ramamurthy C, Bupathi M, Bracarda S, Wright P, Hepp Z, Carret AS, Yu Y, Dillon R, Kataria R, Beaumont JL, Purnajo I, Rosenberg JE. Milowsky MI, et al. Among authors: hepp z. J Clin Oncol. 2024 Apr 20;42(12):1403-1414. doi: 10.1200/JCO.23.01547. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215355 Free PMC article. Clinical Trial.

3

Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy-Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling.

Galsky MD, Wirtz HS, Bloudek B, Hepp Z, Farrar M, Timmons J, Lenero E, Powles T. Galsky MD, et al. Among authors: hepp z. Clin Epidemiol. 2023 Jun 21;15:765-773. doi: 10.2147/CLEP.S409791. eCollection 2023. Clin Epidemiol. 2023. PMID: 37366420 Free PMC article.

4

Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.

Wirtz HS, Hepp Z, Grewal S, Wright P, Fuldeore R, Tomicki S, Hirsch J, Dieguez G, Blakely LJ. Wirtz HS, et al. Among authors: hepp z. Am J Manag Care. 2023 May 1;29(5):e136-e142. doi: 10.37765/ajmc.2023.89338. Am J Manag Care. 2023. PMID: 37229787 Free article.

5

Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility.

Morgans AK, Galsky MD, Wright P, Hepp Z, Chang N, Willmon CL, Sesterhenn S, Liu Y, Sonpavde GP. Morgans AK, et al. Among authors: hepp z. Urol Oncol. 2023 Aug;41(8):357.e11-357.e21. doi: 10.1016/j.urolonc.2023.03.012. Epub 2023 May 17. Urol Oncol. 2023. PMID: 37208230

6

Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC).

Bloudek L, Wright P, McKay C, Derleth CL, Lill JS, Lenero E, Hepp Z, Ramsey SD, Sullivan SD, Devine B. Bloudek L, et al. Among authors: hepp z. Curr Oncol. 2023 Mar 26;30(4):3637-3647. doi: 10.3390/curroncol30040277. Curr Oncol. 2023. PMID: 37185390 Free PMC article.

7

Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology.

Bloudek B, Wirtz HS, Hepp Z, Timmons J, Bloudek L, McKay C, Galsky MD. Bloudek B, et al. Among authors: hepp z. Clin Epidemiol. 2022 Nov 14;14:1375-1386. doi: 10.2147/CLEP.S377093. eCollection 2022. Clin Epidemiol. 2022. PMID: 36404878 Free PMC article.

8

Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada.

Alimohamed N, Grewal S, Wirtz HS, Hepp Z, Sauvageau S, Boyne DJ, Brenner DR, Cheung WY, Jarada TN. Alimohamed N, et al. Among authors: hepp z. Curr Oncol. 2022 Oct 12;29(10):7587-7597. doi: 10.3390/curroncol29100599. Curr Oncol. 2022. PMID: 36290876 Free PMC article.

9

Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy.

Morgans AK, Grewal S, Hepp Z, Fuldeore R, Odak S, Macahilig C, Shillington AC, Sonpavde G. Morgans AK, et al. Among authors: hepp z. Clin Genitourin Cancer. 2022 Dec;20(6):543-552. doi: 10.1016/j.clgc.2022.08.002. Epub 2022 Aug 6. Clin Genitourin Cancer. 2022. PMID: 36088235

10

Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controls.

Galsky MD, Grewal S, Liu Y, Fuldeore R, Sesterhenn S, Chang N, Hepp Z. Galsky MD, et al. Among authors: hepp z. Urol Oncol. 2022 Sep;40(9):411.e9-411.e18. doi: 10.1016/j.urolonc.2022.06.013. Epub 2022 Aug 1. Urol Oncol. 2022. PMID: 35927156 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page